Background: Old Age Security (OAS) represents an public policy through which income-related inequalities in health may be improved. The goal of this cross-sectional study was to investigate the health benefits of receiving OAS in financially insecure older Canadians.
Methods: Using data from the Canadian Longitudinal Study on Aging (CLSA) (n=15,691), ordered logistic regression was used to measure associations between financial insecurity and allostatic load.
Results: Receiving OAS as highest personal income source appeared to remove the health penalty of being financially insecure. While financial insecurity was associated with worse allostatic load in both males and females not receiving OAS, those receiving OAS as highest personal income source had better allostatic load compared to other financially insecure older adults (OR: 0.398, 95 % CI: 0.227, 0.696; OR: 0.677, 95 % CI: 0.483, 0.949).
Discussion: While longitudinal data would be needed to draw causal inferences, these results suggest OAS may play a role improving health outcomes and narrowing income-related health inequalities. Such findings may have important implications on older adults, other vulnerable populations, and future directions of Canadian health and public policy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.healthpol.2024.105054 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surrogate endpoints in mature B-cell neoplasms - meaningful or misleading?
Leukemia
January 2025
Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
Indolent mature B-cell neoplasms are a group of diseases in which recent therapeutic advances have led to an improved overall survival (OS) extending beyond several years. While cause of celebration for patients and caregivers, the increasingly long observation periods necessary to capture treatment effects are complicating trial design and possibly hindering swift access to more effective therapies. Surrogate endpoints are a tool with the potential of earlier study readouts, however, their validity needs to be proven in each individual disease and therapeutic setting.
View Article and Find Full Text PDFPractice of Electroconvulsive Therapy in Catalonia in 2022: Results From a Large Cross-Sectional Survey.
J ECT
December 2024
Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, Barcelona, Catalunya, Spain.
Article Synopsis
- The ECT Working Group of the Catalan Society of Psychiatry conducted a survey in 2022 across 20 public hospitals in Catalonia to examine variations in electroconvulsive therapy (ECT) practices.
- The survey included 50 questions covering organization, technique, therapeutic strategies, and resource management, identifying major depression as the primary reason for ECT in 80% of centers.
- Key findings highlighted consistent ECT application rates, a growing complexity in procedures emphasizing quality and safety, and the need for improvements in resource management and team training.
Quantitative susceptibility mapping of the fear circuit: Associations with silent symptoms in relapsing-remitting multiple sclerosis.
Neuroradiol J
December 2024
Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
Multiple sclerosis (MS) is a long-term autoimmune inflammatory disorder that affects the central nervous system leading to neurodegeneration, and can involve a variety of symptoms. These symptoms can include fatigue, anxiety, depression, and cognitive decline, which may be silent. The objective of this study was to explore changes in brain iron deposition in people with relapsing-remitting MS (pw-RRMS) compared to healthy controls (HCs), with a particular focus on regions of fear circuit.
View Article and Find Full Text PDFParenteral prostacyclin utilization in patients with pulmonary arterial hypertension in the intermediate-risk strata: a retrospective chart review and cross-sectional survey.
BMC Pulm Med
November 2024
Inova Fairfax Hospital, University of Virginia School of Medicine, 3300 Gallows Road, IHVI, Falls Church, VA, 22042, USA.
Background: Current clinical guidelines support use of parenteral prostacyclin therapy for patients with pulmonary arterial hypertension (PAH) at intermediate risk. The objective of this study was to assess parenteral prostacyclin therapy use among patients at intermediate risk according to the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA) 2.0 four-strata risk assessment model.
View Article and Find Full Text PDFAssociation between type III collagen degradation and local tissue damage of a single joint.
Osteoarthr Cartil Open
December 2024
Nordic Bioscience A/S, Herlev, Denmark.
Objective: The development of disease-modifying drugs is limited by OA's heterogeneity and the challenge of defining clinical endpoints. Serological biomarkers are considered potential surrogate endpoints, but their contribution from single joints to systemic levels in OA patients is unclear. In this exploratory study we longitudinally assessed systemic biomarker levels' response to tissue damage and healing before and after surgery in patients undergoing knee or hip joint replacement revision for aseptic failure.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!